Regencell Bioscience Holdings Limited Ordinary Shares
RGCNASDAQMarket cap
$14.13B
Employees
10
Exchange
NASDAQ
About Regencell Bioscience Holdings Limited Ordinary Shares
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
Country
US
Website
www.regencellbioscience.com